Avidity Biosciences (RNA) Stock Forecast, Price Target & Predictions
RNA Stock Forecast
Avidity Biosciences stock forecast is as follows: an average price target of $54.50 (represents a 28.05% upside from RNA’s last price of $42.56) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
RNA Price Target
RNA Analyst Ratings
Buy
Avidity Biosciences Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 24, 2024 | Corinne Johnson | Goldman Sachs | $59.00 | $43.50 | 35.63% | 38.63% |
Jun 12, 2024 | Yanan Zhu | Wells Fargo | $50.00 | $28.92 | 72.89% | 17.48% |
10
Avidity Biosciences Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 2 |
Avg Price Target | - | $59.00 | $54.50 |
Last Closing Price | $42.56 | $42.56 | $42.56 |
Upside/Downside | -100.00% | 38.63% | 28.05% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 30, 2024 | Goldman Sachs | Buy | Buy | Hold |
Oct 21, 2024 | Needham | Buy | Buy | Hold |
Oct 21, 2024 | Goldman Sachs | Underperform | Underperform | Hold |
Oct 21, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 03, 2024 | Goldman Sachs | Buy | Buy | Hold |
Sep 24, 2024 | Goldman Sachs | - | Buy | Initialise |
Sep 16, 2024 | Evercore Partners | Underperform | Underperform | Hold |
Sep 16, 2024 | Needham | Buy | Buy | Hold |
Aug 28, 2024 | Barclays | - | Overweight | Initialise |
Aug 12, 2024 | Needham | Buy | Buy | Hold |
10
Avidity Biosciences Financial Forecast
Avidity Biosciences Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.82M | $2.32M | $2.23M | $2.77M | $2.48M | $2.18M | $1.79M | $1.85M | $2.16M | $2.61M | $2.70M | $2.14M | $1.75M | $1.54M |
Avg Forecast | $4.59M | $4.26M | $3.95M | $3.66M | $4.03M | $3.58M | $3.58M | $3.58M | $2.43M | $4.07M | $2.63M | $2.57M | $12.21M | $2.21M | $2.14M | $2.04M | $2.16M | $2.13M | $2.11M | $1.90M | $2.17M | $2.13M | $1.94M | $1.00M | $838.75K | $575.00K | $700.00K |
High Forecast | $4.59M | $4.26M | $3.95M | $3.66M | $4.03M | $3.58M | $3.58M | $3.58M | $2.43M | $4.20M | $2.63M | $2.57M | $23.86M | $2.21M | $2.14M | $2.04M | $2.16M | $2.13M | $2.11M | $1.90M | $2.17M | $2.13M | $1.94M | $1.00M | $838.75K | $575.00K | $700.00K |
Low Forecast | $4.59M | $4.26M | $3.95M | $3.66M | $4.03M | $3.58M | $3.58M | $3.58M | $2.43M | $3.94M | $2.63M | $2.57M | $570.98K | $2.21M | $2.14M | $2.04M | $2.16M | $2.13M | $2.11M | $1.90M | $2.17M | $2.13M | $1.94M | $1.00M | $838.75K | $575.00K | $700.00K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27% | 1.08% | 1.09% | 1.28% | 1.17% | 1.03% | 0.94% | 0.85% | 1.02% | 1.35% | 2.70% | 2.55% | 3.04% | 2.20% |
Forecast
Avidity Biosciences EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-58.06M | $-52.63M | $-57.60M | $-53.23M | $-44.56M | $-45.98M | $-34.15M | $-38.33M | $-29.10M | $-26.21M | $-23.74M | $-16.16M | $-11.34M | $-10.35M |
Avg Forecast | $-4.59M | $-4.26M | $-3.95M | $-3.66M | $-4.03M | $-3.58M | $-3.58M | $-3.58M | $-2.43M | $-4.07M | $-2.63M | $-2.57M | $-12.21M | $-2.21M | $-2.14M | $-2.04M | $-2.16M | $-2.13M | $-2.11M | $-37.46M | $-2.17M | $-2.13M | $-1.94M | $-20.35M | $-838.75K | $-575.00K | $-29.11M |
High Forecast | $-4.59M | $-4.26M | $-3.95M | $-3.66M | $-4.03M | $-3.58M | $-3.58M | $-3.58M | $-2.43M | $-3.94M | $-2.63M | $-2.57M | $-570.98K | $-2.21M | $-2.14M | $-2.04M | $-2.16M | $-2.13M | $-2.11M | $-29.97M | $-2.17M | $-2.13M | $-1.94M | $-16.28M | $-838.75K | $-575.00K | $-23.29M |
Low Forecast | $-4.59M | $-4.26M | $-3.95M | $-3.66M | $-4.03M | $-3.58M | $-3.58M | $-3.58M | $-2.43M | $-4.20M | $-2.63M | $-2.57M | $-23.86M | $-2.21M | $-2.14M | $-2.04M | $-2.16M | $-2.13M | $-2.11M | $-44.95M | $-2.17M | $-2.13M | $-1.94M | $-24.41M | $-838.75K | $-575.00K | $-34.93M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 26.23% | 24.54% | 28.17% | 24.64% | 20.97% | 21.76% | 0.91% | 17.62% | 13.69% | 13.53% | 1.17% | 19.27% | 19.72% | 0.36% |
Forecast
Avidity Biosciences Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-52.36M | $-47.02M | $-47.19M | $-47.72M | $-42.27M | $-44.47M | $-34.01M | $-38.53M | $-29.27M | $-26.34M | $-23.83M | $-16.26M | $-11.41M | $-10.74M |
Avg Forecast | $-107.03M | $-107.05M | $-104.14M | $-104.18M | $-101.66M | $-98.08M | $-91.91M | $-90.68M | $-93.99M | $-87.77M | $-93.29M | $-98.22M | $-81.35M | $-93.35M | $-97.85M | $-103.44M | $-109.70M | $-99.79M | $-82.26M | $-38.09M | $-74.58M | $-72.39M | $-76.19M | $-20.44M | $-36.62M | $-39.03M | $-29.69M |
High Forecast | $-107.03M | $-107.05M | $-104.14M | $-104.18M | $-101.66M | $-98.08M | $-91.91M | $-72.80M | $-36.15M | $-87.77M | $-93.29M | $-98.22M | $10.54M | $-93.35M | $-97.85M | $-103.44M | $-109.70M | $-99.79M | $-82.26M | $-30.47M | $-74.58M | $-72.39M | $-76.19M | $-16.35M | $-36.62M | $-39.03M | $-23.75M |
Low Forecast | $-107.03M | $-107.05M | $-104.14M | $-104.18M | $-101.66M | $-98.08M | $-91.91M | $-107.28M | $-150.02M | $-87.77M | $-93.29M | $-98.22M | $-132.56M | $-93.35M | $-97.85M | $-103.44M | $-109.70M | $-99.79M | $-82.26M | $-45.70M | $-74.58M | $-72.39M | $-76.19M | $-24.53M | $-36.62M | $-39.03M | $-35.63M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.56% | 0.48% | 0.46% | 0.43% | 0.42% | 0.54% | 0.89% | 0.52% | 0.40% | 0.35% | 1.17% | 0.44% | 0.29% | 0.36% |
Forecast
Avidity Biosciences SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $13.73M | $12.28M | $12.06M | $10.38M | $10.09M | $8.69M | $8.57M | $7.43M | $6.61M | $6.27M | $5.88M | $4.82M | $3.76M | $2.92M |
Avg Forecast | $15.38M | $14.26M | $13.23M | $12.28M | $13.51M | $12.00M | $12.00M | $12.00M | $8.13M | $13.64M | $8.80M | $8.61M | $40.92M | $7.42M | $7.19M | $6.85M | $7.24M | $7.03M | $6.99M | $6.28M | $7.19M | $7.03M | $6.41M | $3.31M | $2.77M | $1.90M | $2.32M |
High Forecast | $15.38M | $14.26M | $13.23M | $12.28M | $13.51M | $12.00M | $12.00M | $12.00M | $8.13M | $14.07M | $8.80M | $8.61M | $79.94M | $7.42M | $7.19M | $6.85M | $7.24M | $7.03M | $6.99M | $6.28M | $7.19M | $7.03M | $6.41M | $3.31M | $2.77M | $1.90M | $2.32M |
Low Forecast | $15.38M | $14.26M | $13.23M | $12.28M | $13.51M | $12.00M | $12.00M | $12.00M | $8.13M | $13.22M | $8.80M | $8.61M | $1.91M | $7.42M | $7.19M | $6.85M | $7.24M | $7.03M | $6.99M | $6.28M | $7.19M | $7.03M | $6.41M | $3.31M | $2.77M | $1.90M | $2.32M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.85% | 1.71% | 1.76% | 1.43% | 1.44% | 1.24% | 1.36% | 1.03% | 0.94% | 0.98% | 1.78% | 1.74% | 1.98% | 1.26% |
Forecast
Avidity Biosciences EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.71 | $-0.66 | $-0.67 | $-0.83 | $-0.80 | $-0.89 | $-0.70 | $-1.63 | $-0.68 | $-0.70 | $-0.64 | $-0.43 | $-0.30 | $-1.25 |
Avg Forecast | $-0.87 | $-0.87 | $-0.84 | $-0.84 | $-0.82 | $-0.80 | $-0.74 | $-0.73 | $-0.76 | $-0.71 | $-0.76 | $-0.80 | $-0.66 | $-0.76 | $-0.79 | $-0.84 | $-0.89 | $-0.93 | $-0.77 | $-0.80 | $-0.70 | $-0.68 | $-0.71 | $-0.56 | $-0.34 | $-0.36 | $-0.36 |
High Forecast | $-0.87 | $-0.87 | $-0.84 | $-0.84 | $-0.82 | $-0.80 | $-0.74 | $-0.59 | $-0.29 | $-0.71 | $-0.76 | $-0.80 | $0.09 | $-0.76 | $-0.79 | $-0.84 | $-0.89 | $-0.93 | $-0.77 | $-0.80 | $-0.70 | $-0.68 | $-0.71 | $-0.56 | $-0.34 | $-0.36 | $-0.36 |
Low Forecast | $-0.87 | $-0.87 | $-0.84 | $-0.84 | $-0.82 | $-0.80 | $-0.74 | $-0.87 | $-1.22 | $-0.71 | $-0.76 | $-0.80 | $-1.07 | $-0.76 | $-0.79 | $-0.84 | $-0.89 | $-0.93 | $-0.77 | $-0.80 | $-0.70 | $-0.68 | $-0.71 | $-0.56 | $-0.34 | $-0.36 | $-0.36 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 0.83% | 0.80% | 0.93% | 0.86% | 1.16% | 0.88% | 2.34% | 1.00% | 0.98% | 1.15% | 1.26% | 0.82% | 3.46% |
Forecast
Avidity Biosciences Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
BCEL | Atreca | $0.09 | $4.00 | 4344.44% | Buy |
PASG | Passage Bio | $0.54 | $6.00 | 1011.11% | Buy |
BDTX | Black Diamond Therapeutics | $2.43 | $14.75 | 507.00% | Buy |
RLAY | Relay Therapeutics | $4.64 | $19.40 | 318.10% | Buy |
PLRX | Pliant Therapeutics | $12.85 | $39.71 | 209.03% | Buy |
DAWN | Day One Biopharmaceuticals | $13.34 | $38.80 | 190.85% | Buy |
ARVN | Arvinas | $25.11 | $71.00 | 182.76% | Buy |
STOK | Stoke Therapeutics | $11.27 | $30.60 | 171.52% | Buy |
CGEM | Cullinan Oncology | $12.22 | $31.50 | 157.77% | Buy |
MLYS | Mineralys Therapeutics | $11.87 | $30.00 | 152.74% | Buy |
IGMS | IGM Biosciences | $8.89 | $20.33 | 128.68% | Buy |
SWTX | SpringWorks Therapeutics | $36.30 | $67.33 | 85.48% | Buy |
AKRO | Akero Therapeutics | $31.20 | $46.00 | 47.44% | Buy |
RNA | Avidity Biosciences | $42.56 | $54.50 | 28.05% | Buy |
PTGX | Protagonist Therapeutics | $41.65 | $50.00 | 20.05% | Buy |
RVMD | Revolution Medicines, Inc. Warrant | $56.78 | $60.63 | 6.78% | Buy |
CERE | Cerevel Therapeutics | $44.96 | $33.50 | -25.49% | Buy |